Terms: = Breast cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4
1421 results:
1. Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human breast cancer.
Wescott EC; Sun X; Gonzalez-Ericsson P; Hanna A; Taylor BC; Sanchez V; Bronzini J; Opalenik SR; Sanders ME; Wulfkuhle J; Gallagher RI; Gomez H; Isaacs C; Bharti V; Wilson JT; Ballinger TJ; Santa-Maria CA; Shah PD; Dees EC; Lehmann BD; Abramson VG; Hirst GL; Brown Swigart L; van ˈt Veer LJ; Esserman LJ; Petricoin EF; Pietenpol JA; Balko JM
Cancer Res Commun; 2024 Apr; 4(4):1120-1134. PubMed ID: 38687247
[TBL] [Abstract] [Full Text] [Related]
2. Lidocaine effects on neutrophil extracellular trapping and angiogenesis biomarkers in postoperative breast cancer patients with different anesthesia methods: a prospective, randomized trial.
Zhang W; Liu J; Li X; Bai Z; Sun Y; Chen X
BMC Anesthesiol; 2024 Apr; 24(1):162. PubMed ID: 38678209
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA DLG5-AS1 facilitates breast cancer cell proliferation and invasion by promoting EZH2-mediated transcriptional silencing of SFRP1.
Cai Y; Liu Y; Sun Y; Ren Y
Arch Biochem Biophys; 2024 Jun; 756():110018. PubMed ID: 38677505
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
[TBL] [Abstract] [Full Text] [Related]
5. B7-H3 Expression in breast cancer and Brain Metastasis.
Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
[TBL] [Abstract] [Full Text] [Related]
6. Phase II Study of Erdafitinib in Patients With Tumors With
Gong J; Mita AC; Wei Z; Cheng HH; Mitchell EP; Wright JJ; Ivy SP; Wang V; Gray RC; McShane LM; Rubinstein LV; Patton DR; Williams PM; Hamilton SR; Alva AS; Tricoli JV; Conley BA; Arteaga CL; Harris LN; O'Dwyer PJ; Chen AP; Flaherty KT
JCO Precis Oncol; 2024 Apr; 8():e2300406. PubMed ID: 38603651
[TBL] [Abstract] [Full Text] [Related]
7. Therapeutic potential of LINS01 histamine H
Ospital IA; Táquez Delgado MA; Nicoud MB; Corrêa MF; Borges Fernandes GA; Andrade IW; Lauretta P; Martínez Vivot R; Comba MB; Zanardi MM; Speisky D; Uriburu JL; Fernandes JPS; Medina VA
Biomed Pharmacother; 2024 May; 174():116527. PubMed ID: 38579399
[TBL] [Abstract] [Full Text] [Related]
8. Quantitative Pattern of hPTMs by Mass Spectrometry-Based Proteomics with Implications for Triple-Negative breast cancer.
Liu C; Xu M; Li W; Cao X; Wang Y; Chen H; Zhang T; Lu M; Xie H; Chen Y
J Proteome Res; 2024 Apr; 23(4):1495-1505. PubMed ID: 38576392
[TBL] [Abstract] [Full Text] [Related]
9. Nucleosome reorganisation in breast cancer tissues.
Jacob DR; Guiblet WM; Mamayusupova H; Shtumpf M; Ciuta I; Ruje L; Gretton S; Bikova M; Correa C; Dellow E; Agrawal SP; Shafiei N; Drobysevskaja A; Armstrong CM; Lam JDG; Vainshtein Y; Clarkson CT; Thorn GJ; Sohn K; Pradeepa MM; Chandrasekharan S; Brooke GN; Klenova E; Zhurkin VB; Teif VB
Clin Epigenetics; 2024 Apr; 16(1):50. PubMed ID: 38561804
[TBL] [Abstract] [Full Text] [Related]
10. Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in fgfr1-amplified breast cancer cells.
Chi F; Griffiths JI; Nath A; Bild AH
Breast Cancer Res; 2024 Mar; 26(1):54. PubMed ID: 38553760
[TBL] [Abstract] [Full Text] [Related]
11. Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer.
Lin J; Zhong W; Lyu Z; Peng J; Rong Y; Zeng K; Lai J; Wu D; Wang J; Li Y; Zheng J; Zhang J; Pan Z
Cancer Lett; 2024 May; 589():216825. PubMed ID: 38548218
[TBL] [Abstract] [Full Text] [Related]
12. A Lipopeptidomimetic of Transcriptional Activation Domains Selectively Disrupts the Coactivator Med25 Protein-Protein Interactions.
Pattelli ON; Valdivia EM; Beyersdorf MS; Regan CS; Rivas M; Hebert KA; Merajver SD; Cierpicki T; Mapp AK
Angew Chem Int Ed Engl; 2024 May; 63(21):e202400781. PubMed ID: 38527936
[TBL] [Abstract] [Full Text] [Related]
13. Histone H3.1 is a chromatin-embedded redox sensor triggered by tumor cells developing adaptive phenotypic plasticity and multidrug resistance.
Palma FR; Coelho DR; Pulakanti K; Sakiyama MJ; Huang Y; Ogata FT; Danes JM; Meyer A; Furdui CM; Spitz DR; Gomes AP; Gantner BN; Rao S; Backman V; Bonini MG
Cell Rep; 2024 Mar; 43(3):113897. PubMed ID: 38493478
[TBL] [Abstract] [Full Text] [Related]
14. Adjuvant Ovarian Function Suppression in Premenopausal Hormone Receptor-Positive breast cancer.
Basmadjian RB; Lupichuk S; Xu Y; Quan ML; Cheung WY; Brenner DR
JAMA Netw Open; 2024 Mar; 7(3):e242082. PubMed ID: 38477918
[TBL] [Abstract] [Full Text] [Related]
15. Impact of Histone Lysine Methyltransferase SUV4-20H2 on cancer Onset and Progression with Therapeutic Potential.
Papadaki S; Piperi C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473745
[TBL] [Abstract] [Full Text] [Related]
16. Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic breast cancer Patients.
Canino F; Tornincasa A; Bettelli S; Manfredini S; Barbolini M; Moscetti L; Omarini C; Toss A; Tamburrano F; Antonelli G; Baglio F; Belluzzi L; Martinelli G; Natalizio S; Ponzoni O; Dominici M; Piacentini F
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473737
[TBL] [Abstract] [Full Text] [Related]
17. Correlation between ferroptosis and adriamycin resistance in breast cancer regulated by transferrin receptor and its molecular mechanism.
Yu X; Cheng L; Liu S; Wang M; Zhang H; Wang X; Zhang H; Yang Z; Wu S
FASEB J; 2024 Mar; 38(5):e23550. PubMed ID: 38466338
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
19. Design, synthesis, and biological evaluation of selective covalent inhibitors of FGFR4.
Chen X; Li H; Lin Q; Dai S; Qu L; Guo M; Zhang L; Liao J; Wei H; Xu G; Jiang L; Chen Y
Eur J Med Chem; 2024 Mar; 268():116281. PubMed ID: 38432058
[TBL] [Abstract] [Full Text] [Related]
20. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
[TBL] [Abstract] [Full Text] [Related]
[Next]
